Shares of Advaxis, Inc. (NASDAQ: ADXS), a clinical-stage biotech developing novel cancer immunotherapies, are sinking after the company provided a business update along with a third-quarter earnings ...
Add Yahoo as a preferred source to see more of our stories on Google. By Vidya L Nathan (Reuters) - Advaxis Inc said its experimental cancer vaccine was found more effective in improving survival ...
Women suffering from breast cancer. The two diseases may appear unrelated, but the Princeton-based biotech company Advaxis Inc. is eager to exploit the connection: Dogs with bone cancer express the ...
PRINCETON, N.J., March 19, 2015 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, announced that the first patient was dosed in ...
We are just a few weeks into the year, and already shares of Advaxis ( ADXS) are up by more than 60%. But that's nothing. The shares have fully quadrupled since their November lows. Advaxis stock has ...
PRINCETON, N.J., Feb. 11, 2015 -- Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration agreement with ...
Ayala Pharmaceuticals Inc., a clinical-stage oncology company headquartered in Delaware, and Princeton-based biotech firm Advaxis Inc. announced Oct. 19 that they entered into a definitive merger ...
Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer
MONMOUTH JUNCTION, N.J., June 29, 2022 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy ...
MONMOUTH JUNCTION, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Advaxis, Inc. (OTCQX: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results